login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ENVIRONMENTAL IMPACT ACQUI-A (ENVI) Stock News
USA
- NASDAQ:ENVI -
US29413T1060
-
Common Stock
8.82
+0.25 (+2.92%)
Last: 2/2/2022, 8:46:36 PM
8.8
-0.02 (-0.23%)
After Hours:
2/2/2022, 8:46:36 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ENVI Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Kaskela Law LLC
- Mentions:
GRNA
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of GreenLight Biosciences Holdings and Encourages Long-Term GRNA / ENVI Shareholders to Contact the Firm
4 years ago - By: GreenLight Biosciences, Inc.
GreenLight Biosciences begins trading today as Nasdaq: GRNA on the closing of its business combination with Environmental Impact Acquisition Corp.
4 years ago - By: BusinessInsider
- Mentions:
GRNA
Environmental Impact Acquisition Corporation approval obtained; GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022
4 years ago - By: GreenLight Biosciences, Inc.
GreenLight Biosciences and Germains Seed Technology Partner to Explore Development of World's First dsRNA Seed Treatment to Control Pests
4 years ago - By: BusinessInsider
ENVI and GreenLight Biosciences Announce Filing of Definitive Proxy Statement/Prospectus and the February 1st, 2022 Special Meeting to Approve Proposed Business Combination
4 years ago - By: GreenLight Biosciences, Inc.
ENVI and GreenLight Biosciences Announce Filing of Definitive Proxy Statement/Prospectus and the February 1st, 2022 Special Meeting to Approve Proposed Business Combination
4 years ago - By: GreenLight Biosciences, Inc.
GreenLight Biosciences expands RTP footprint for the next generation of agricultural products
4 years ago - By: GreenLight Biosciences, Inc.
GreenLight (ENVI) and IAVI begin work on Omicron variant-adapted COVID-19 vaccine candidate
4 years ago - By: GreenLight Biosciences, Inc.
GreenLight Biosciences (ENVI) partners with IAVI to accelerate COVID-19 vaccine trial in Africa
4 years ago - By: Samsung Biologics
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
4 years ago - By: GreenLight Biosciences, Inc.
Greenlight Biosciences (ENVI) Adds Two World-Renowned Scientists To Its Scientific Advisory Board
4 years ago - By: GreenLight Biosciences
GreenLight Biosciences opens RNA production facility for the next generation of agricultural products
4 years ago - By: Benzinga
RNA Tech Vaccine Developer GreenLight Biosciences Riding To NASDAQ Debut Via $1.5B SPAC Deal
Please enable JavaScript to continue using this application.